ATProto Browser

{
  "text": "Our newest work reveals that SARS-CoV-2 evolved to produce a truncated version of its N protein to antagonize antiviral responses. This 'mini' N, called N*M210, sequesters dsRNA, blocks interferon activation, defeats RNaseL & disassembles stress granules and p-bodies. www.biorxiv.org/content/10.1...",
  "$type": "app.bsky.feed.post",
  "embed": {
    "$type": "app.bsky.embed.external",
    "external": {
      "uri": "https://www.biorxiv.org/content/10.1101/2025.02.15.638421v1",
      "thumb": {
        "$type": "blob",
        "ref": {
          "$link": "bafkreihvqmida6zwixvkda66jiewk4pq5ycgik3r2tbo7ofn56m2hkdo44"
        },
        "mimeType": "image/jpeg",
        "size": 262369
      },
      "title": "A truncated SARS-CoV-2 nucleocapsid protein enhances virus fitness by evading antiviral responses",
      "description": "Viruses face a selective pressure to evade cellular antiviral responses to control the outcome of an infection. However, due to their limited genome size, viruses must adopt unique strategies to confr..."
    }
  },
  "langs": [
    "en"
  ],
  "facets": [
    {
      "index": {
        "byteEnd": 300,
        "byteStart": 269
      },
      "features": [
        {
          "uri": "https://www.biorxiv.org/content/10.1101/2025.02.15.638421v1",
          "$type": "app.bsky.richtext.facet#link"
        }
      ]
    }
  ],
  "createdAt": "2025-02-27T03:35:43.695Z"
}